期刊文献+

头孢吡肟治疗胸科术后重症肺部感染疗效分析

Clinical observation of cefepime in treating severe pulmonary infections following thoracic surgery.
原文传递
导出
摘要 目的观察头孢吡肟治疗胸科术后重症肺部感染的疗效及安全性。方法 19例胸科术后重症肺部感染患者采用头孢吡肟治疗 ,剂量 1g ,每 8小时 1次 ,静脉注射 ,疗程 5~ 7天 ,结果总有效率为 89.4 % ,细菌阴转率为 84 .6 % ,细菌清除率为 93.5 % ,无不良反应。 31株致病菌作药物敏感试验 ,头孢吡肟的敏感率为 10 0 % ,与泰能抗菌活性相似 ,较头孢唑啉、头孢哌酮及环丙沙星的敏感率高。结论头孢吡肟治疗胸科术后重症肺部感染安全、有效。 Objective To observe the therapeutic effect and safety of cefepime in treating severe pulmonary infections following thoracic surgery. Methods 19 cases of severe pulmonary infections following thoracic surgery were treated with 1g cefepime, once every 8 hours for a course of 5 7 days. Results The overall effect rate was 89.4%, bacteria negative converting rate was 84.6%, and bacteria clearance rate was 93.5%. No side effect related to medicine occurred. The sensitivity rate of cefepime to medicine was 100% in the medicine sensitivity to medicine test of 31 bacterial strains. Compared with the anti bacterial activity of Taineng, cefepime was the same as jaineny more sensitive than cefazolin and cefoperazone as well as ciprofloxacin. Conclusion Cefepime is an effective agent for severe pulmonary infections following thoracic surgery.
出处 《中国综合临床》 北大核心 2003年第9期817-818,共2页 Clinical Medicine of China
关键词 头孢吡肟 肺部感染 围术期治疗 Cefepime Pulmonary infections Perioperative treatment
  • 相关文献

参考文献5

  • 1唐英春,张扣兴,张天托,饶宪,周凤丽,毕筱刚,陈正贤,郭纪全,林材元,钟维农.头孢吡肟治疗下呼吸道细菌感染79例[J].中国新药杂志,2001,10(2):115-117. 被引量:10
  • 2Giamarellou H. Fourth generation cephalosporins in the antimicrobial chemotherapy of surgical infections[ J ]. J Chemother, 1999, 11(6) :486-493.
  • 3Sheng WH, Wang JT. Chang SC. Efficacy and safety of ccfepime in the treatment of serious bacterial infections in hospitalized adult patients[J]. J Microbiol Immunol Infect, 2000, 33 (2) : 109-114.
  • 4Cunha BA, Shea KW. Emergence of antimicrobial resistance in community-acquired pulmonary pathogens[J]. Semin Respir Infect,1998, 13 (1) :43-53.
  • 5Okamoto MP, Nakahiro RK, Chin A, et al. Cefepime clinical pharmacokinetics. Clin Pharmacokinet[J]. 1993, 25 (2) : 88-102

二级参考文献3

  • 1[1]Grassi GG,Grassi C.Cefepime:overview of activity in vitro and in vivo[J].J Antimicrob Chemother,1993,32(Suppl B)∶87-94.
  • 2[2]Okamoto MP,Nakahiro RK,Chin A,et al. Cefepime clinical pharmacokinetics[J].Clin Pharmacokinet,1993,25∶88-102.
  • 3[3]Thornsberry C,Brown SD,Yee YC,et al.In vitro activity of cefepime and other antimicrobials:survey of European isolates[J].J Antimicrob Chem other,1993,32(SupplB)∶31-53.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部